MustGrow Biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) announced that its board of directors has authorized and approved the grant of a total of 1,660,315 deferred share units (DSUs) and restricted share units (RSUs) to certain company directors, officers, and consultants, effective September 25, 2025.
On settlement, each DSU will entitle the holder to receive one MustGrow Biologics common share or a cash payment equivalent thereof at the discretion of the company.